Andros Pharmaceuticals Co (ROCO:6917) Days Sales Outstanding : 110.98 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co Days Sales Outstanding?

Andros Pharmaceuticals Co's average Accounts Receivable for the six months ended in Jun. 2024 was NT$0.05 Mil. Andros Pharmaceuticals Co's Revenue for the six months ended in Jun. 2024 was NT$0.07 Mil. Hence, Andros Pharmaceuticals Co's Days Sales Outstanding for the six months ended in Jun. 2024 was 110.98.

The historical rank and industry rank for Andros Pharmaceuticals Co's Days Sales Outstanding or its related term are showing as below:

ROCO:6917' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.14 Med: 672.62 Max: 1479.5
Current: 48.14

During the past 5 years, Andros Pharmaceuticals Co's highest Days Sales Outstanding was 1479.50. The lowest was 48.14. And the median was 672.62.

ROCO:6917's Days Sales Outstanding is ranked better than
70.8% of 863 companies
in the Biotechnology industry
Industry Median: 72.59 vs ROCO:6917: 48.14

Andros Pharmaceuticals Co's Days Sales Outstanding declined from Jun. 2023 (1,296.86) to Jun. 2024 (110.98).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Andros Pharmaceuticals Co Days Sales Outstanding Historical Data

The historical data trend for Andros Pharmaceuticals Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co Days Sales Outstanding Chart

Andros Pharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

636.96

80.33

708.27

1,479.50

Andros Pharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial				16.10	879.70	1,296.86	29.26	110.98

Competitive Comparison of Andros Pharmaceuticals Co's Days Sales Outstanding

For the Biotechnology subindustry, Andros Pharmaceuticals Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Andros Pharmaceuticals Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's Days Sales Outstanding falls into.

Andros Pharmaceuticals Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Andros Pharmaceuticals Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (6.491	+	0.035)	/	2 )	/	0.805	*	365
=	3.263					/	0.805	*	365
=	1,479.50

Andros Pharmaceuticals Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (0.035	+	0.055)	/	2 )	/	0.074	*	365 / 2
=	0.045					/	0.074	*	365 / 2
=	110.98

Andros Pharmaceuticals Co (ROCO:6917) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Andros Pharmaceuticals Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Andros Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261

Website

http://www.androspharma.com

Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co Headlines

No Headlines